Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 174.90
Bid: 174.50
Ask: 174.90
Change: -0.50 (-0.29%)
Spread: 0.40 (0.229%)
Open: 172.90
High: 175.10
Low: 171.80
Prev. Close: 175.40
N91 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

3 Nov 2023 07:05

RNS Number : 2433S
Ninety One PLC
03 November 2023
 

Ninety One plc ? ? Ninety One Limited

Incorporated in England and Wales ? Incorporated in the Republic of South Africa

Registration number 12245293 ? Registration number 2019/526481/06

Date of registration: 4 October 2019 ? Date of registration: 18 October 2019

LSE share code: N91 ? JSE share code: NY1

JSE share code: N91 ? ? ISIN: ZAE000282356

ISIN: GB00BJHPLV88

 

As part of the dual-listed company structure, the boards of Ninety One plc and Ninety One Limited (together the 'Board') notify both the London Stock Exchange and the JSE Limited ('JSE') of matters which are required to be disclosed under the FCA Disclosure Guidance and Transparency Rules and Listing Rules of the United Kingdom Listing Authority (the 'UKLA') and/or the JSE Listings Requirements (the 'Listing Requirements').

 

Ninety One Limited Ordinary Share Buyback

Ninety One Limited (the 'Company') advises that, at the close of business on 01 November 2023, it has cumulatively repurchased 8,900,922 of the Company's ordinary shares ('Ordinary Shares') representing 3.007% of the issued Ordinary Share capital as at the date of the general authority granted by shareholders at the Company's annual general meeting held on 26 July 2023 ('General Authority').

The Ordinary Shares were repurchased for an aggregate value of R345,632,678.38. Details of the repurchase are set out in the table hereunder:

 

Repurchase period

Number and percentage of shares repurchased

Highest repurchase price per share (R)

Lowest repurchase price per share (R)

Aggregate value (R)

Number and percentage of shares outstanding in relation to the total shares under the General Authority

27 July -

1 November 2023

8,900,922

3.007%

R40.00

R35.89

R345,632,678.38

20,695,450

6.993%

 

An application will be made to the JSE to de-list 307,360 Ordinary Shares, at which point they will be immediately cancelled. 8,593,562 Ordinary Shares have already been cancelled. The Ordinary Shares remaining in issue following the cancellation of the aforementioned shares amounts to 287,062,798. The Company does not hold any treasury shares.

 

The impact of the repurchase of the Ordinary Shares on the financial information of the Company is immaterial. The Ordinary Shares were repurchased from excess cash resources of the Company; going forward, no Ordinary Share dividends will be payable on the repurchased Ordinary Shares and interest earned on the cash utilised for the repurchases will be foregone. 

 

On 27 July 2023, in accordance with paragraph 5.72(h) of the JSE Listings Requirements, the Company entered into a mandate (the 'Mandate') with an independent agent to undertake its repurchase programme. Under the Mandate, the repurchase programme continued during the Company's closed period from 1 October to 15 November 2023. The repurchases were made in terms of the current General Authority effected through an order book operated by the JSE and executed without any prior understanding or arrangement between the Company and the counterparties. Accordingly, the Company has complied with paragraph 5.72(a) of the Listings Requirements.

 

 

Statement by the Board

The Board has considered the effect of the repurchases and is of the opinion that, for a period of 12 months following the repurchases, the:

? Company and its subsidiaries (the 'Group') will be able, in the ordinary course of business, to pay its debts;

? consolidated assets of the Company and the Group will be in excess of the consolidated liabilities;

? share capital and reserves of the Company and the Group will be adequate for ordinary business purposes; and

? working capital of the Company and the Group will be adequate for ordinary business purposes.

 

 

For enquiries please contact:

 

Investor relations

Alvar Fernandez alvar.fernandez@ninetyone.com +44 (0) 20 3938 2305

Jakub Vojtek jakub.vojtek@ninetyone.com +44 (0) 20 3938 2413

 

 

Date of release: ?03 November 2023

JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKFAEEEDFFA
Date   Source Headline
13th Jul 20203:30 pmRNSDealing in Securities by Employee Benefit Trust
8th Jul 202012:30 pmRNSAnnual Financial Report and Notice of AGM
7th Jul 20201:00 pmRNSDealing in Securities by Employee Benefit Trust
3rd Jul 202012:00 pmRNSDirector/PDMR Shareholding
1st Jul 202012:00 pmRNSDealing in Securities by Employee Benefit Trust
29th Jun 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
29th Jun 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
25th Jun 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
25th Jun 202012:02 pmRNSPrice Monitoring Extension
25th Jun 202011:00 amRNSDealing in Securities by Employee Benefit Trust
22nd Jun 20202:00 pmRNSDealing in Securities by Employee Benefit Trust
18th Jun 20203:30 pmRNSDealing in Securities by Employee Benefit Trust
16th Jun 202012:07 pmRNSSecond Price Monitoring Extn
16th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
9th Jun 20203:00 pmRNSDirector/PDMR Shareholding
9th Jun 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
8th Jun 20202:00 pmRNSDealing in Securities by Employee Benefit Trust
3rd Jun 20204:00 pmRNSDealing in Securities by Employee Benefit Trusts
3rd Jun 20204:00 pmRNSHolding(s) in Company
2nd Jun 20203:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:30 pmRNSDealing in Securities by Employee Benefit Trusts
1st Jun 20202:00 pmRNSDealing in Securities by Employee Benefit Trusts
26th May 20203:00 pmRNSDealing in Securities by Employee Benefit Trusts
21st May 20203:00 pmRNSDealing in Securities by Employee Benefit Trust
20th May 20207:00 amRNSFinal Results
13th May 202012:02 pmRNSPrice Monitoring Extension
12th May 202012:02 pmRNSPrice Monitoring Extension
3rd Apr 20203:00 pmRNSAppointment of Joint Corporate Broker
3rd Apr 202010:32 amRNSHolding(s) in Company
31st Mar 202012:05 pmRNSDirector/PDMR Shareholding
30th Mar 202010:40 amRNSDirector/PDMR Shareholding
26th Mar 202010:00 amRNSDirector/PDMR Shareholding
25th Mar 202011:45 amRNSDirector/PDMR Shareholding
24th Mar 20203:25 pmRNSHolding(s) in Company
24th Mar 202012:40 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20202:00 pmRNSDirector/PDMR Shareholding
20th Mar 20204:40 pmRNSPrice Monitoring Extension
20th Mar 202012:00 pmRNSDirector/PDMR Shareholding
20th Mar 202011:00 amRNSTRP121 Aquisition of Beneficial Interest
20th Mar 20209:00 amRNSTRP121 Disposal of Beneficial Interest
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
19th Mar 20201:00 pmRNSDirector/PDMR Shareholding
19th Mar 202010:35 amRNSDirector/PDMR Shareholding
19th Mar 20207:05 amRNSDealing In Securities By Employee Benefit Trust
19th Mar 20207:00 amRNSDealing In Securities By Employee Benefit Trust
18th Mar 20204:35 pmRNSPrice Monitoring Extension
18th Mar 202011:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.